# Corium Innovations, Inc.: Phase 1 study in Healthy Female Participants, Postmenopause (68 participants)

**Score:** 40/100

| Field | Value |
|---|---|
| Sponsor | Corium Innovations, Inc. |
| Sponsor type | Industry (pharma, biotech, medtech) |
| Study | A Study to Assess the Bioavailability and Adhesion of Estradiol/Levonorgestrel TDS in Healthy Post-Menopausal Female Participants |
| NCT ID | NCT07851649 |
| Phase | Phase 1 |
| Status | completed |
| Conditions | Healthy Female Participants; Postmenopause |
| Intervention types | drug |
| Target enrollment | 68 |
| Site countries | India |
| Posted | 2026-10-01 |
| Planned start | 2026-07-01 |
| Event | Newly registered study |
| Event date | 2026-10-01 |

## Why this score
- Industry sponsor (buys outsourced services).

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07851649). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.